Product Code: HLC204A
Report Highlights:
The global market for transcatheter treatment devices should grow from $4.0 billion in 2018 to $8.0 billion by 2023 at a compound annual growth rate (CAGR) of 14.8% for the period of 2018-2023.
U.S. market for transcatheter treatment devices should grow from $2.3 billion in 2018 to $4.8 billion by 2023 at a CAGR of 15.5% for the period of 2018-2023.
Asia-Pacific market for transcatheter treatment devices should grow from $214.0 million in 2018 to $460.0 million by 2023 at a CAGR of 16.5% for the period of 2018-2023.
Report Scope:
Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR, and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic.)
- Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR, and TMVI devices.
- Market characterization, unmet need, market size, and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2023.
- Competition and market shares.
- Key marketed and pipeline (R&D) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Pricing and reimbursement.
- Observations and conclusions on the future of transcatheter treatment.
- Profiles of market participants and associations.
Report Includes:
- 28 data tables and 25 additional tables
- An overview of the global market for transcatheter treatment technologies
- Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Analyses of the market by procedure segments, treatment approaches, and by region
- Detailed market sizing and analyses of the various transcatheter devices and technologies in use or under development
- Description of qualitative and quantitative factors that are driving the global market
- Description of key marketed and pipeline devices and technologies
- Profiles of major companies of the industry including, Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd. And Valcare Inc.
Table of Contents
Chapter 1: Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology and Information Sources
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2: Summary and Highlights
Chapter 3: Structural Heart Valve Disease
- Structural Heart Disease
- Spectrum of Structural Heart Disease
- Valvular Heart Disease
- Symptoms and Risk Factors of Structural Heart Disease
- Causes of Structural Heart Disease
- Rheumatic Fever
- Mitral Valve Prolapse
- Peripheral Artery Disease
- Cardiovascular Disease
- Aortic Aneurysm
- Obesity
- Diagnosis of Structural Heart Disease
- Treatment of Structural Heart Disease
- Management Through Medication
- Surgical Intervention: Heart Valve Repair and Replacement
- Tobacco Smoking and Heart Disease
- Aging, Gender, and Structural Heart Diseases
- Global Demographics
- U.S. Demographics
- European Demographics
- Japanese Demographics
- Current Challenges and Future Directions
Chapter 4: Aortic Valve Disease
- Disease Overview
- Types of Aortic Stenosis
- Acquired Aortic Stenosis
- Congenital Aortic Stenosis
- Mild and Moderate Aortic Stenosis
- Severe Aortic Stenosis
- Asymptomatic Aortic Stenosis
- Symptomatic Aortic Stenosis
- Causes, Risk Factors, and Symptoms
- Causes
- Symptoms
- Risk Factors
- Epidemiology and Economic Burden
- Diagnosis
- Standard Doppler Echocardiography
- Multimodality Imaging
- Other Techniques
- Treatment
- Open Surgical Treatment (SAVR)
- Transcatheter Treatment (TAVR/TAVI)
- Aortic Valve Repair Versus Aortic Valve Replacement
- Types of Transcatheter Approaches
- Open Surgical Repair (SAVR) Versus Transcatheter Treatment (TAVR/TAVI)
- TAVR and TAVI Complications
- Key Marketed and Pipeline Products
- Key Marketed Products
- Key Pipeline/R&D Products
- Self-expandable Versus Balloon-expandable Devices
- Unmet Need
- Current Challenges and Future Developments
Chapter 5: Mitral Valve Disease
- Disease Overview
- Types of Mitral Regurgitation
- Degenerative Mitral Regurgitation
- Functional Mitral Regurgitation
- Mild and Moderate Mitral Stenosis
- Severe Mitral Stenosis
- Asymptomatic Mitral Stenosis
- Symptomatic Mitral Stenosis
- Causes, Risk Factors, and Symptoms
- Causes
- Symptoms
- Risk Factors
- Epidemiology and Economic Burden
- Diagnosis
- Standard Echocardiography
- Multimodality Imaging
- Other Techniques
- Treatment
- Open Surgical Treatment (SMVR)
- Transcatheter Treatment (TMVR and TMVI)
- Mitral Valve Repair Versus Mitral Valve Replacement
- Types of Transcatheter Approaches
- Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
- TMVR Complications
- Key Marketed and Pipeline Products
- Key Marketed Products
- Key Pipeline/R&D Products
- Other Less Invasive (MIS) Mitral Valve Technologies
- Unmet Need
- Current Challenges and Future Developments
Chapter 6: Market Size and Growth Analysis
- Market Size and Growth Analysis
- Market Size and Growth Analysis, by Region
- Market Size and Growth Analysis, by Segment
- Market Size and Growth Analysis, by Procedure Approach
- Market Size and Growth Analysis, by Procedure (TAVR/TAVI and TMVR)
- Heart Valve Market: Traditional Heart Valves (Tissue Heart Valves and Mechanical Heart Valves) Versus Transcatheter Heart Valves
- Market Growth Drivers and Restraints
- Market Growth Drivers
Chapter 7: Competitive Landscape in Transcatheter Treatment Devices Market
- Competitive Landscape in Transcatheter Treatment Devices Market
Chapter 8: Market Strategies in the Transcatheter Treatment Devices Market
- Market Consolidation in Cardiovascular Devices Market
- Mergers and Acquisitions in Transcatheter Treatment Devices Market
- Recent Mergers and Acquisitions
- Venus Medtech Acquired Intervalve Inc.
- LivaNova PLC Acquired Caisson Interventional LLC
- Boston Scientific Acquired Symetis SA
- Boston Scientific Acquired Neovasc's Advanced Biological Tissue Manufacturing Assets along with 15% Stake in Neovasc Inc.
- Edwards Lifesciences Acquired Valtech Cardio Ltd.
- Venus Medtech Inc. Acquired Transcatheter Technologies' Technology Portfolio
- Medtronic Acquired Twelve Inc.
- Abbott Acquired Tendyne Holdings
- Edwards Lifesciences Acquired CardiAQ Valve Technologies Inc.
- Micro Interventional Devices Acquired Endovalve Inc.
- Boston Scientific Acquired Sadra Medical Inc.
- LoneStar Heart Acquired Cardiopolymers Inc.
- Abbott Laboratories Acquired Evalve Inc.
- Medtronic Acquired Ventor Technologies Ltd.
- The Bracco Group acquired Heart Leaflet Technologies Inc. (HLT)
- Minority Stakes and Future Options to Acquire
- Abbott Laboratories Secures an Option to Buy Cephea Valve Technologies Inc.
- Sorin Acquired Minority Stake in HighLife SAS
- Boston Scientific Secures an Option to Buy MValve Technologies Ltd.
- Sorin Group Acquired Minority Stake in Cardiosolutions Inc.
- Future Strategic Landscape
Chapter 9: Regulatory Structure: Medical Devices
- Regulatory Systems for Medical Devices, by Region
- U.S.
- European Union (EU)
- Japan
Chapter 10: Pricing and Reimbursement: Medical Devices
- Pricing and Reimbursement Background
- Pricing and Reimbursement for Medical Devices, by Region
Chapter 11: Conclusions-Outlook for Transcatheter Treatment Devices
- Major Developments Influencing the Market
- Technological Developments
- Demographic and Economic Trends
- Changing Structure of the Healthcare Industry
- Long-term Outlook for Transcatheter Treatments
Chapter 12: Company Profiles
- ABBOTT LABORATORIES
- BIOTRONIK
- BOSTON SCIENTIFIC CORP.
- BRACCO SPA
- BRAILE BIOMEDICA
- CARDIAC DIMENSIONS INC.
- CEPHEA VALVE TECHNOLOGIES INC.
- COLIBRI HEART VALVE LLC
- DIRECT FLOW MEDICAL INC.
- EDWARDS LIFESCIENCES CORP.
- GORMAN CARDIOVASCULAR RESEARCH GROUP
- HANSEN MEDICAL INC. (SUBSIDIARY OF AURIS HEALTH INC.)
- HIGHLIFE SAS
- JENAVALVE TECHNOLOGY INC.
- LABORATORIES INVALV
- LIVANOVA PLC
- LONESTAR HEART INC.
- MEDTRONIC INC.
- MICRO INTERVENTIONAL DEVICES INC.
- MICROPORT SCIENTIFIC
- MITRAGEN INC.
- MITRALIX LTD.
- MITRALTECH LTD.
- MITRASSIST LTD.
- MITRICARES SAS
- MITRAL HEAL LTD.
- MITRALIGN INC.
- MVRX INC.
- NAKOSTECH SARL
- NAVIGATE CARDIAC STRUCTURES INC.
- NEOVASC INC.
- NEW VALVE TECHNOLOGY (NVT) AG
- SINO MEDICAL SCIENCE TECHNOLOGY INC.
- ST. JUDE MEDICAL INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
- TAU-PNU MEDICAL CO. LTD.
- THUBRIKAR AORTIC VALVE INC.
- TRANSCATHETER TECHNOLOGIES GMBH
- TRANSMURAL SYSTEMS
- VASCULAR INNOVATIONS CO. LTD.
- VALCARE INC.
- VALVEXCHANGE INC.
- VENUS MEDTECH INC.
Chapter 13: Appendix A: List of Acronyms
Chapter 14: Appendix B: Professional Organizations
- American Heart Association
- Center for Drug Evaluation and Research (CDER)
- Center for Devices and Radiological Health (CDRH)
- Centers for Medicare & Medicaid Services (CMS)
- European Databank for Medical Devices (EUDAMED)
- Food and Drug Administration (FDA or USFDA)
- Hormone Foundation
- International Diabetes Federation (IDF)
- International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- Network for Excellence in Health Innovation (NEHI)
- National Center for Biotechnology Information (NCBI)
- National Institute of Aging (NIA)
- Pharmaceuticals and Medical Devices Agency (PMDA)
- World Cancer Research Fund International
- World Health Organization (WHO)
